Stock Comparison

KYMR vs REGN

Kymera Therapeutics Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

KYMR

Kymera Therapeutics Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$9.32B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

—

17.1

Price/Sales

88.8

5.2

Price/Book

6.3

2.5

EV/EBITDA

-10.0

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-612.17%

29.65%

Operating Margin

-697.81%

24.32%

Return on Equity

-24.10%

14.00%

Return on Assets

-15.60%

6.53%

Growth (YoY)

Revenue Growth

466.40%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

2.0

0.2

52-Week High

$119.35

$810.12

52-Week Low

$40.69

$553.38

Analyst Target

$131.00

$833.54

Compare KYMR and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.